Rucaparib

Rucaparib is a targeted cancer medication that helps treat certain types of ovarian, prostate, and breast cancers by interfering with the cancer cells' ability to repair their DNA. Cancer cells rely on specific pathways to fix damage; Rucaparib blocks these pathways, causing the cells to accumulate damage and eventually die. It is particularly effective in cancers with specific genetic mutations, such as BRCA mutations. By selectively targeting these vulnerabilities, Rucaparib offers a more precise treatment option with potentially fewer side effects compared to traditional chemotherapy.